Literature DB >> 26125962

Vulvar and Vaginal Atrophy: Physiology, Clinical Presentation, and Treatment Considerations.

Ahinoam Lev-Sagie1.   

Abstract

Vulvovaginal atrophy is a common condition associated with decreased estrogenization of the vaginal tissue. Symptoms include vaginal dryness, irritation, itching, soreness, burning, dyspareunia, discharge, urinary frequency, and urgency. It can occur at any time in a woman's life cycle, although more commonly in the postmenopausal phase, during which the prevalence is approximately 50%. Despite the high prevalence and the substantial effect on quality of life, vulvovaginal atrophy often remains underreported and undertreated. This article aims to review the physiology, clinical presentation, assessment, and current recommendations for treatment, including aspects of effectiveness and safety of local vaginal estrogen therapies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26125962     DOI: 10.1097/GRF.0000000000000126

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  18 in total

1.  Vaginal estrogen use and chronic disease risk in the Nurses' Health Study.

Authors:  Shilpa N Bhupathiraju; Francine Grodstein; Meir J Stampfer; Walter C Willett; Carolyn J Crandall; Jan L Shifren; JoAnn E Manson
Journal:  Menopause       Date:  2018-12-17       Impact factor: 2.953

2.  Impact of vertical versus horizontal vaginal cuff closure on vaginal length following hysterectomy: a meta-analysis of randomized trials.

Authors:  Vasilios Pergialiotis; Georgios Daskalakis; Nikolaos Thomakos; Dimitrios Haidopoulos; Dimitrios Loutradis; Alexandros Rodolakis
Journal:  Int Urogynecol J       Date:  2019-01-29       Impact factor: 2.894

Review 3.  Light and energy based therapeutics for genitourinary syndrome of menopause: Consensus and controversies.

Authors:  Yona Tadir; Adrian Gaspar; Ahinoam Lev-Sagie; Macrene Alexiades; Red Alinsod; Alex Bader; Alberto Calligaro; Jorge A Elias; Marco Gambaciani; Jorge E Gaviria; Cheryl B Iglesia; Ksenija Selih-Martinec; Patricia L Mwesigwa; Urska B Ogrinc; Stefano Salvatore; Paolo Scollo; Nicola Zerbinati; John Stuart Nelson
Journal:  Lasers Surg Med       Date:  2017-02-21       Impact factor: 4.025

4.  Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.

Authors:  Irina A Zalenskaya; Neelima Chandra; Nazita Yousefieh; Xi Fang; Oluwatosin E Adedipe; Suzanne S Jackson; Sharon M Anderson; Christine K Mauck; Jill L Schwartz; Andrea R Thurman; Gustavo F Doncel
Journal:  J Clin Invest       Date:  2018-09-17       Impact factor: 14.808

Review 5.  Vaginal Health During Breast Cancer Treatment.

Authors:  Sandy J Falk; Sharon Bober
Journal:  Curr Oncol Rep       Date:  2016-05       Impact factor: 5.075

Review 6.  Vulvodynia.

Authors:  Sophie Bergeron; Barbara D Reed; Ursula Wesselmann; Nina Bohm-Starke
Journal:  Nat Rev Dis Primers       Date:  2020-04-30       Impact factor: 52.329

Review 7.  Animal Models and Alternatives in Vaginal Research: a Comparative Review.

Authors:  Jennifer M McCracken; Gisele A Calderon; Andrew J Robinson; Courtney N Sullivan; Elizabeth Cosgriff-Hernandez; Julie C E Hakim
Journal:  Reprod Sci       Date:  2021-04-06       Impact factor: 2.924

8.  Patient acceptability and satisfaction with a low-dose solubilized vaginal estradiol softgel capsule, TX-004HR.

Authors:  Sheryl A Kingsberg; Robin Kroll; Irwin Goldstein; Harvey Kushner; Brian Bernick; Shelli Graham; Sebastian Mirkin; Ginger D Constantine
Journal:  Menopause       Date:  2017-08       Impact factor: 2.953

9.  Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trial.

Authors:  James A Simon; David F Archer; Risa Kagan; Brian Bernick; Shelli Graham; Ginger D Constantine; Sebastian Mirkin
Journal:  Menopause       Date:  2017-09       Impact factor: 2.953

Review 10.  Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?

Authors:  D Edwards; N Panay
Journal:  Climacteric       Date:  2015-12-26       Impact factor: 3.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.